eBC and mBC Treatment | KISQALI® (ribociclib)
learn about hr+, her2- metastatic breast cancer treatment in premenopausal and postmenopausal women with kisqali. see full prescribing & safety info.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 27.385 |
| 2025-03 | 39.433 |
| 2025-04 | 49.411 |
| 2025-05 | 53.507 |
| Source | Traffic Share |
|---|---|
| search | 49.12% |
| direct | 36.19% |
| paid referrals | 6.00% |
| referrals | 5.19% |
| social | 3.42% |
| 0.07% |
| Region | Percentage |
|---|---|
| United States | 97.65% |
| United Kingdom | 2.35% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| kisqali | 1,128 | 11,280 | $33.07 |
| kisquali testimonials | 3 | 30 | $0.00 |
| kisqali® side effect | 8 | 80 | $0.00 |
| breast cancer symptoms | 9,976 | 99,760 | $0.00 |
| what are some early signs of breast cancer that can sometimes go unnoticed | 6 | 60 | $0.00 |